PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

NCT02933255 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: PROSTVAC-V/F
DRUG: Nivolumab
PROCEDURE: Prostatectomy
PROCEDURE: Biopsy
DRUG: Tylenol

Sponsor

National Cancer Institute (NCI)